We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.55B
AUM Growth
-$472M
Cap. Flow
-$301M
Cap. Flow %
-3.99%
Top 10 Hldgs %
20.77%
Holding
863
New
59
Increased
344
Reduced
256
Closed
128

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$25.4M
2
ABBV icon
AbbVie
ABBV
+$21.9M
3
KYNB
Kyntra Bio
KYNB
+$19.2M
4
WM icon
Waste Management
WM
+$19M
5
GILD icon
Gilead Sciences
GILD
+$17.7M

Sector Composition

Rank Sector Weight
1 Healthcare 31.81%
2 Technology 18.27%
3 Financials 10.05%
4 Consumer Discretionary 9.39%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EA icon
126
Electronic Arts
EA
$52.4B
$14.2M 0.19%
144,874
+38,509
+36% +$3.62M
DFS
127
DELISTED
Discover Financial Services
DFS
$14.1M 0.19%
174,279
-32,686
-16% -$2.7M
MDCO
128
DELISTED
Medicines Co
MDCO
$14.1M 0.19%
281,500
+60,000
+27% +$2.39M
AWK icon
129
American Water Works
AWK
$26.3B
$13.9M 0.18%
112,206
-2,177
-2% -$263K
INFY icon
130
Infosys
INFY
$45B
$13.9M 0.18%
1,220,722
+29,676
+2% +$334K
BAC icon
131
Bank of America
BAC
$435B
$13.8M 0.18%
473,473
-60,155
-11% -$1.73M
AERI
132
DELISTED
Aerie Pharmaceuticals
AERI
$13.4M 0.18%
699,800
+95,000
+16% +$2.18M
AMT icon
133
American Tower
AMT
$77.7B
$13.4M 0.18%
60,606
-878
-1% -$192K
PLD icon
134
Prologis
PLD
$138B
$13.3M 0.18%
155,773
+50,765
+48% +$4.2M
FTV icon
135
Fortive
FTV
$19B
$13.2M 0.18%
305,712
+9,659
+3% +$445K
ELV icon
136
Elevance Health
ELV
$81.9B
$12.9M 0.17%
53,824
-21,933
-29% -$6.01M
ANET icon
137
Arista Networks
ANET
$219B
$12.7M 0.17%
853,216
+160,096
+23% +$2.48M
VRNS icon
138
Varonis Systems
VRNS
$5.25B
$12.6M 0.17%
633,969
-158,091
-20% -$3.52M
ON icon
139
ON Semiconductor
ON
$33.8B
$12.6M 0.17%
653,319
+62,765
+11% +$1.21M
KMB icon
140
Kimberly-Clark
KMB
$36.4B
$12.5M 0.17%
88,193
-17,372
-16% -$2.39M
AZTA icon
141
Azenta
AZTA
$1.26B
$12.5M 0.17%
+337,439
New +$12.2M
ES icon
142
Eversource Energy
ES
$28.2B
$12.5M 0.17%
145,921
+41,131
+39% +$3.27M
SYK icon
143
Stryker
SYK
$127B
$12.4M 0.16%
57,403
-11,998
-17% -$2.57M
SLAB icon
144
Silicon Laboratories
SLAB
$7.15B
$12.3M 0.16%
110,894
-19,494
-15% -$2.11M
HOLI
145
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$12.2M 0.16%
806,023
+5,593
+0.7% +$92.8K
EXEL icon
146
Exelixis
EXEL
$13.9B
$12.1M 0.16%
682,342
-55,000
-7% -$1.11M
OLED icon
147
Universal Display
OLED
$3.71B
$12.1M 0.16%
71,837
+13,348
+23% +$2.67M
BIDU icon
148
Baidu
BIDU
$35.8B
$12.1M 0.16%
117,259
+80,852
+222% +$8.69M
CHTR icon
149
Charter Communications
CHTR
$14.7B
$12M 0.16%
29,067
+1,013
+4% +$409K
HCA icon
150
HCA Healthcare
HCA
$84.8B
$12M 0.16%
99,309
-660
-0.7% -$85.3K

Similar funds

Candriam SCA's Q3 2019 Portfolio in Review

As of Q3 2019, Candriam SCA held 863 positions worth $7.55B, down 5.9% from $8.02B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA withdrew a net $301M in Q3 2019, closing 128 positions and reducing 256 holdings. Its most notable exit was Celgene Corp, an estimated $70.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Nike worth $27.8M.

  • Candriam SCA's largest Q3 2019 buy was Nike: 295,763 shares worth $27.8M.
  • Candriam SCA added most to AbbVie in Q3 2019, an estimated $21.9M increase.
  • Candriam SCA's biggest Q3 2019 reduction was Biogen, cutting an estimated $43.3M.
  • Candriam SCA fully exited Celgene Corp in Q3 2019, selling an estimated $70.2M.
  • Candriam SCA's ten largest holdings make up 21% of its $7.55B portfolio in Q3 2019.
  • Candriam SCA opened 59 new positions and closed 128 in Q3 2019.
  • Candriam SCA's portfolio value fell 5.9% quarter-over-quarter to $7.55B.

Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.